These success, along with a former report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of targeting ACKR3 as a singular method to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected Ailments. January 3, 2024 Donating is https://moseleyq849omn9.wikicorrespondent.com/user